Do newer agents confer added cost-benefit in the management of hypertension?
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D006801:Humans; D006973:Hypertension / Q000191:economics*
D000959:Antihypertensive Agents